These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 2542966)

  • 1. Toxic shock syndrome toxin 1 binds to major histocompatibility complex class II molecules.
    Scholl P; Diez A; Mourad W; Parsonnet J; Geha RS; Chatila T
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4210-4. PubMed ID: 2542966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of toxic shock syndrome toxin-1 to murine major histocompatibility complex class II molecules.
    Scholl PR; Sekaly RP; Diez A; Glimcher LH; Geha RS
    Eur J Immunol; 1990 Sep; 20(9):1911-6. PubMed ID: 2209697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 bind to distinct sites on HLA-DR and HLA-DQ molecules.
    Scholl PR; Diez A; Geha RS
    J Immunol; 1989 Oct; 143(8):2583-8. PubMed ID: 2551962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The staphylococcal toxic shock syndrome toxin 1 triggers B cell proliferation and differentiation via major histocompatibility complex-unrestricted cognate T/B cell interaction.
    Mourad W; Scholl P; Diaz A; Geha R; Chatila T
    J Exp Med; 1989 Dec; 170(6):2011-22. PubMed ID: 2584933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptors for toxic shock syndrome toxin-1 and staphylococcal enterotoxin A on human blood monocytes.
    See RH; Krystal G; Chow AW
    Can J Microbiol; 1992 Sep; 38(9):937-44. PubMed ID: 1281444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules.
    Uchiyama T; Tadakuma T; Imanishi K; Araake M; Saito S; Yan XJ; Fujikawa H; Igarashi H; Yamaura N
    J Immunol; 1989 Nov; 143(10):3175-82. PubMed ID: 2509554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1.
    Karp DR; Teletski CL; Scholl P; Geha R; Long EO
    Nature; 1990 Aug; 346(6283):474-6. PubMed ID: 2377209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissection of the function of HLA class II and costimulation in B cell-mediated and toxic shock syndrome toxin-1-induced T cell proliferation.
    Dennig D; O'Reilly RJ
    J Immunol; 1993 Jun; 150(12):5231-40. PubMed ID: 7685791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative activities of distinct isotypes of murine and human major histocompatibility complex class II molecules in binding toxic shock syndrome toxin 1 and determination of CD antigens expressed on T cells generated upon stimulation by the toxin.
    Uchiyama T; Saito S; Inoko H; Yan XJ; Imanishi K; Araake M; Igarashi H
    Infect Immun; 1990 Dec; 58(12):3877-82. PubMed ID: 2123824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for differential binding of staphylococcal enterotoxin A and toxic shock syndrome toxin 1 to class II major histocompatibility molecules.
    Pontzer CH; Russell JK; Johnson HM
    Proc Natl Acad Sci U S A; 1991 Jan; 88(1):125-8. PubMed ID: 1986357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of HLA-DR alpha chain residues critical for binding of the toxic shock syndrome toxin superantigen.
    Panina-Bordignon P; Fu XT; Lanzavecchia A; Karr RW
    J Exp Med; 1992 Dec; 176(6):1779-84. PubMed ID: 1460432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of human T cells by toxic shock syndrome toxin-1: the toxin-binding structures expressed on human lymphoid cells acting as accessory cells are HLA class II molecules.
    Uchiyama T; Imanishi K; Saito S; Araake M; Yan XJ; Fujikawa H; Igarashi H; Kato H; Obata F; Kashiwagi N
    Eur J Immunol; 1989 Oct; 19(10):1803-9. PubMed ID: 2583222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of isotypes and allelic polymorphism on the binding of staphylococcal exotoxins to MHC class II molecules.
    Scholl PR; Diez A; Karr R; Sekaly RP; Trowsdale J; Geha RS
    J Immunol; 1990 Jan; 144(1):226-30. PubMed ID: 2404064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DO increases bacterial superantigen binding to human MHC molecules by inhibiting dissociation of class II-associated invariant chain peptides.
    Pezeshki AM; Azar GA; Mourad W; Routy JP; Boulassel MR; Denzin LK; Thibodeau J
    Hum Immunol; 2013 Oct; 74(10):1280-7. PubMed ID: 23756162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of human vascular endothelial cells by IFN-gamma: acquisition of HLA class II expression, TSST-1-binding activity and accessory activity in T cell activation by the toxin.
    Araake M; Uchiyama T; Imanishi K; Yan XJ
    Int Arch Allergy Appl Immunol; 1991; 96(1):55-61. PubMed ID: 1752697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of IgE synthesis by staphylococcal toxic shock syndrome toxin-1 in peripheral blood mononuclear cells from patients with atopic dermatitis.
    Hofer MF; Lester MR; Schlievert PM; Leung DY
    Clin Exp Allergy; 1995 Dec; 25(12):1218-27. PubMed ID: 8821303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 21-mer synthetic peptide of toxic shock syndrome toxin 1, TSST-1[58-78], activates T cells by binding to MHC class II and by an MHC unrestricted xenostimulatory pathway.
    Haregewoin A; Edwin C; Hom RC; Finberg R
    Immunol Invest; 1994 Nov; 23(6-7):413-20. PubMed ID: 7851959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality.
    Kum WW; Laupland KB; Chow AW
    Can J Microbiol; 2000 Feb; 46(2):171-9. PubMed ID: 10721486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective binding of bacterial toxins to major histocompatibility complex class II-expressing cells is controlled by invariant chain and HLA-DM.
    Lavoie PM; Thibodeau J; Cloutier I; Busch R; Sékaly RP
    Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6892-7. PubMed ID: 9192662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification from a phage display library of peptides that bind to toxic shock syndrome toxin-1 and that inhibit its binding to major histocompatibility complex (MHC) class II molecules.
    Sato A; Ida N; Fukuyama M; Miwa K; Kazami J; Nakamura H
    Biochemistry; 1996 Aug; 35(32):10441-7. PubMed ID: 8756700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.